Clinical Trial Update: A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral ixazomib as maintenance therapy in newly diagnosed multiple myeloma patients who did not undergo stem cell transplantation has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ixazomib (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2020-11-10